Search for: "State v. L. B." Results 6161 - 6180 of 6,573
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 May 2008, 9:09 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: WHO members near accord on global strategy on IP and health: (Intellectual Property Watch), (GenericsWeb), (Gowlings), (IAM), Copiepresse seeks up to €49 million from Google in lawsuit over right to feature links to publishers’ content on internet: (IPKat), (Ars Technica), (Techdirt), (Out-Law), (IP Law360) Singapore ‘image… [read post]
29 Jun 2023, 3:11 am by Jan von Hein
Waterkotte: Provisional injunctions under unfair competition law The Higher Regional Court of Hamburg addressed the delimitation between Art. 7(1) and (2) of the Brussels Ibis Regulation after Wikingerhof v. [read post]
12 Jun 2008, 6:08 pm
Escherichia coli O157:H7 Infections in Children Associated with Raw Milk and Raw Colostrum From Cows --- California, 2006 CDC this morning published the following findings in MMWR: Five of six patients reported they had consumed brand A raw dairy products in the week before their illness onset; the sixth patient denied drinking brand A raw milk, although his family routinely purchased it. [read post]
3 Feb 2009, 11:08 pm by Sean Hayes
List 2 1,2)l Part A: Same as the basic form. [read post]
13 Feb 2024, 9:09 am by CFM Admin
Principal place of business and, if that address is not in the United States, the primary location of the company in the United States. [read post]
20 Oct 2010, 3:01 pm by Oliver G. Randl
m; (d) at least one dispersing agent; and meeting the following conditions: (1) the percentage in weight of water based on the combined weight of the cement (a) and of the particles (c) lies within the 8-24% range; (2) the metal fibres have an average length l1 of at least 2 mm and an l1/Ø1 ratio of at least 20, Ø1 being the diameter of the fibres; (3) the ratio, V1/V, of the volume V1 of the metal fibres to the volume V of the organic fibres is greater than 1 and the… [read post]
10 Oct 2022, 5:01 am by Robert Liles
Simply stated, Civil Investigative Demands used in False Claims Act investigations are essentially subpoenas authorized under 31 U.S. [read post]
9 Aug 2011, 10:06 am by Roshonda Scipio
(RES) TZ 2 SP33 2011 Civil Rights With all deliberate speed : implementing Brown v. [read post]
3 Sep 2012, 3:15 am by New Books Script
KF 4754.5 R83 2011 Cases and materials on sexual orientation and the law / by William B. [read post]
10 Oct 2007, 9:41 pm
-based DNS expertise and in order to preserve stability, it makes sense to headquarter the new corporation in the United States. [read post]
30 Nov 2009, 1:05 am
S66008 BLURB : V & T L. dwi with child passenger Chapter Signed Date Effective Date 496  11/18/2009 takes effect on (12/18/2009) the thirtieth day after it shall have become a law; provided that §5 and the amendments made to subpar (ii) of par (b) of subd 1 of §1193 of the vehicle and traffic law made by §3, except for those amendments concerning a violation of subd 2-a of §1192 of the vehicle and traffic law,… [read post]
21 Nov 2008, 1:36 pm
(IPKat) EU favours disclosure of computer patents before standards are set (Intellectual Property Watch) Trade Marks Court of First Instance finds RAUTARUUKKI fails to satisfy acquired distinctiveness criterion: Rautaruukki Oyj v OHIM (Class 46) Court of First Instance finds original signature of famous Italian lutist Antonio Stradivari, in arte Stradivarius, of the 17th century, cannot be read by relevant consumers: T‑340/06 (Catch Us If You Can!!!) [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]